Search research articles
Contact Us
Filters
Showing results (81-90 of 1,291) with videos related to
Page
of 130
Sort By:
Journal of Drugs in Dermatology : JDD
|
October 31, 2007
Conversion to positive tuberculosis test during etanercept treatment of psoriasis
William Sumner, Steven R Feldman
Journal of the American Academy of Dermatology
|
September 22, 2007
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments
Jeff Hick, Steven R Feldman
JAMA Dermatology
|
October 15, 2015
In Reply
Steven R Feldman, Kathryn Anderson
Drugs in Context
|
January 20, 2015
The cost of biologics for psoriasis is increasing
Judy Cheng, Steven R Feldman
Dermatology Online Journal
|
November 10, 2021
Characterizing dermatology mobile applications that use artificial intelligence
Varun Ranpariya, Steven R Feldman
Cutis
|
April 19, 2023
More New Therapeutics for Psoriasis
Christina Kontzias, Steven R Feldman
JAMA Dermatology
|
June 6, 2014
Assessing medication adherence using indirect self-report
Hossein Alinia, Steven R Feldman
Journal of Cutaneous Medicine and Surgery
|
February 27, 2026
Amphetamine Use is Common in Patients with Delusional Infestation
Jonmichael Samsel, Steven R Feldman
Cutis
|
June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications
Steven R Feldman, Alan B Fleischer
Archives of Dermatology
|
June 22, 2011
Importance of providing adequate patient information to ensure good adherence and outcomes: comment on "Efficacy of an educational intervention with kidney transplant recipients to promote skin self-examination for squamous cell carcinoma detection"
Michelle M Levender, Steven R Feldman
Page
of 130
Search research articles
Search
Showing results (81-90 of 1,291) with videos related to
Sort By:
Page
of 130
Journal of Drugs in Dermatology : JDD
|
October 31, 2007
Conversion to positive tuberculosis test during etanercept treatment of psoriasis
William Sumner, Steven R Feldman
Journal of the American Academy of Dermatology
|
September 22, 2007
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments
Jeff Hick, Steven R Feldman
JAMA Dermatology
|
October 15, 2015
In Reply
Steven R Feldman, Kathryn Anderson
Drugs in Context
|
January 20, 2015
The cost of biologics for psoriasis is increasing
Judy Cheng, Steven R Feldman
Dermatology Online Journal
|
November 10, 2021
Characterizing dermatology mobile applications that use artificial intelligence
Varun Ranpariya, Steven R Feldman
Cutis
|
April 19, 2023
More New Therapeutics for Psoriasis
Christina Kontzias, Steven R Feldman
JAMA Dermatology
|
June 6, 2014
Assessing medication adherence using indirect self-report
Hossein Alinia, Steven R Feldman
Journal of Cutaneous Medicine and Surgery
|
February 27, 2026
Amphetamine Use is Common in Patients with Delusional Infestation
Jonmichael Samsel, Steven R Feldman
Cutis
|
June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications
Steven R Feldman, Alan B Fleischer
Archives of Dermatology
|
June 22, 2011
Importance of providing adequate patient information to ensure good adherence and outcomes: comment on "Efficacy of an educational intervention with kidney transplant recipients to promote skin self-examination for squamous cell carcinoma detection"
Michelle M Levender, Steven R Feldman
Page
of 130